Drug Target Review2025-01-23T08:00:09
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD).
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2026-06-04T07:05:00
Author Graham Craig
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud